novo septerna - Search News

Order byBest matchMost fresh

News

Novo Nordisk Inks A Major Obesity Deal

Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases.

Continue reading

· 11h · on MSN

Contract Pharma · 2h

Novo Nordisk Invests $2.2B in Septerna’s Oral Drugs

· 1d · on MSN

Novo Nordisk, Septerna Agree $2.2 Billion Obesity Pill Deal

20h

Eli Lilly Shares Tumble After Rival Novo?Nordisk Strikes Major Weight Loss Deal

Meanwhile, Eli Lilly's Zepbound injection has gained traction, prompting both firms to race toward more convenient ...

1don MSN

This biotech’s stock rockets on oral obesity-drug partnership with Wegovy parent

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results